2003Acta Academiae Medicinae JiangxiRequires access

Clinical Efficacy of 5-FU Continuous Infusion Combined with CF, DDP,and HCPT in Patients with Advanced Gastric Carcinoma

He Xin

Open publisher page 0 citations

Abstract

Objective:To evaluate the clinical efficacy and tolerance of CF/5 FU,DDP and HCPT in patients with advanced gastric carcinoma.Methods:A combined chemotherapy scheme of HLEP was used:5 FU 0.5 iv,then 2.5 g/m 2 for 48 hours by continuous infusion,CF 300 mg iv at 0 and 24th hour and HCPT 10 mg/m2/d iv for 5 day as well as DDP 20 mg/d iv for 5 days.The above scheme was repeated every three or four weeks.Results:Of 42 cases of gastric cancer, two had CR and 19 PR,and the response rate(CR+PR) was 50%.The main toxic side effects included stomatitis, diarrhea, alopecia, anorexia,nausea,vomiting and leucopenia.Conclusion:HLFP regimen has a higher response rate in patients with advanced gastric carcinoma.The toxicity is slight and can be well tolerated.

About this research paper

What this paper is about

Objective:To evaluate the clinical efficacy and tolerance of CF/5 FU,DDP and HCPT in patients with advanced gastric carcinoma.Methods:A combined chemotherapy scheme of HLEP was used:5 FU 0.5 iv,then 2.5 g/m 2 for 48 hours by continuous infusion,CF 300 mg iv at 0 and 24th hour and HCPT 10 mg/m2/d iv for 5 day as well as DDP 20 mg/d iv for 5 days.The above scheme was repeated every three or four weeks.Results:Of 42 cases of gastric cancer, two had CR and 19 PR,and the response rate(CR+PR) was 50%.The main toxic side effects included stomatitis, diarrhea, alopecia, anorexia,nausea,vomiting and leucopenia.Conclusion:HLFP regimen has a higher response rate in patients with advanced gastric carcinoma.The toxicity is slight and can be well tolerated.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the clinical efficacy and tolerance of CF/5 FU,DDP and HCPT in patients with advanced gastric carcinoma.Methods:A combined chemotherapy scheme of HLEP was used:5 FU 0.5 iv,then 2.5 g/m 2 for 48 hours by continuous infusion,CF 300 mg iv at 0 and 24th hour and HCPT 10 mg/m2/d iv for 5 day as well as DDP 20 mg/d iv for 5 days.The above scheme was repeated every three or four weeks.Results:Of 42 cases of gastric cancer, two had CR and 19 PR,and the response rate(CR+PR) was 50%.The main toxic side effects included stomatitis, diarrhea, alopecia, anorexia,nausea,vomiting and leucopenia.Conclusion:HLFP regimen has a higher response rate in patients with advanced gastric carcinoma.The toxicity is slight and can be well tolerated.

Key concepts: Medicine, Nausea, Vomiting, Stomatitis, Anorexia, Regimen, Gastroenterology, Diarrhea

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Efficacy of 5-FU Continuous Infusion Combined with CF, DDP,and HCPT in Patients with Advanced Gastric Carcinoma — Research Paper | ScholarLens